Vanguard Group’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-935,064
| Closed | -$19.6M | – | 4134 |
|
|
2016
Q3 | $19.6M | Buy |
935,064
+164,576
| +21% | +$3.44M | ﹤0.01% | 2371 |
|
|
2016
Q2 | $8.31M | Buy |
770,488
+181,223
| +31% | +$1.96M | ﹤0.01% | 2733 |
|
|
2016
Q1 | $3.91M | Buy |
589,265
+168,162
| +40% | +$1.11M | ﹤0.01% | 3092 |
|
|
2015
Q4 | $7.62M | Buy |
421,103
+41,144
| +11% | +$745K | ﹤0.01% | 2780 |
|
|
2015
Q3 | $4.18M | Buy |
379,959
+96,675
| +34% | +$1.06M | ﹤0.01% | 3055 |
|
|
2015
Q2 | $4.08M | Buy |
283,284
+30,512
| +12% | +$439K | ﹤0.01% | 3107 |
|
|
2015
Q1 | $2.96M | Buy |
252,772
+125,095
| +98% | +$1.46M | ﹤0.01% | 3243 |
|
|
2014
Q4 | $2.13M | Buy |
+127,677
| New | +$2.13M | ﹤0.01% | 3264 |
|